ASX · Pharmaceuticals

CSLCSL Limited

$179.01

▲ $3.66 (+2.09%)

15-min delayed · via Yahoo Finance

Loading chart…

📊 Wall Street Consensus

17 analysts rating CSL

Buy

consensus

Strong Buy

5 (29%)

Buy

5 (29%)

Hold

7 (41%)

Sell

0 (0%)

Strong Sell

0 (0%)

12-mo target

$184.21

Range

$150.82 – $218.06

Current

$177.59

Implied move

+3.7%

As of Oct 2026 · Aggregated international analyst data via Yahoo Finance

Data on CSL Limited

Recent CSL News

CSL Shares Have Surged 49%: Are Brokers Finally Turning Bullish?

CSL shares have surged 49% over a period that saw the global biopharmaceuticals company's plasma-derived therapies and vaccine businesses deliver strong earnings recovery, with analyst commentary indicating a shift in broker consensus toward more positive ratings after an extended period o

Aug 28, 2026

Similar Stocks

NYSE

ABBV

AbbVie Inc.

NYSE

MRK

Merck & Co. Inc.

NSE

SUNPHARMA

Sun Pharmaceutical Industries

NSE

DIVISLAB

Divi’s Laboratories Ltd.

NSE

CIPLA

Cipla Ltd.

NSE

DRREDDY

Dr. Reddy’s Laboratories

Data shown is informational only and may be delayed by up to 15 minutes. Not a recommendation to buy, sell, or hold any security. See our disclaimer.